ConductScience.org, home

Paper17575235

[Lys40(Ahx-DTPA-111In)NH2]-Exendin-4 is a highly efficient radiotherapeutic for glucagon-like peptide-1 receptor-targeted therapy for insulinoma.

Wicki A and 10 others. Clin Cancer Res, 2007. Cited by 78 papers, by iCite.

Cite this record

ConductScience Library. [Lys40(Ahx-DTPA-111In)NH2]-Exendin-4 is a highly efficient radiotherapeutic for glucagon-like peptide-1 receptor-targeted therapy for insulinoma. Papers, record 17575235. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17575235

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
[Lys40(Ahx-DTPA-111In)NH2]-Exendin-4 is a highly efficient radiotherapeutic for glucagon-like peptide-1 receptor-targeted therapy for insulinoma.
PubMed
Journal
Clin Cancer Res
PubMed
Year
2007
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
78
iCite
Relative citation ratio, by iCite
2.11
iCite
Revised in PubMed
2016-11-24
PubMed

Authors11

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Wicki AAndreas
2Wild DDamian
3Storch DDaniel
4Seemayer CChristian
5Gotthardt MMartin
6Behe MMartin
7Kneifel SStefan
8Mihatsch MJMichael J
9Reubi JCJean-Claude
10Mäcke HRHelmut R
11Christofori GGerhard

Source PubMed

Download CSV of authors

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Indium RadioisotopesMajor topic
InsulinomaMajor topic
Organometallic CompoundsMajor topic
Pancreatic NeoplasmsMajor topic
PeptidesMajor topic
RadiopharmaceuticalsMajor topic
Receptors, GlucagonMajor topic
Animals
Cell Proliferation
Female
Glucagon-Like Peptide-1 Receptor
Male
Mice
Mice, Transgenic
Pentetic Acid
Radionuclide Imaging
Tissue Distribution

Source PubMed

Download CSV of topics

Cited by43

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 78 citations.

PMIDTitleJournalYearIn PapersSource
41088364Engineered GLP-1R-targeting nanoplatforms: multimodal therapeutics in human diseases.J Nanobiotechnology2025https://conductscience.org/library/papers/41088364PubMed
39911322Unlocking the multifaceted roles of GLP-1: Physiological functions and therapeutic potential.Toxicol Rep2025https://conductscience.org/library/papers/39911322PubMed
37780209Theranostic in GLP-1R molecular imaging: challenges and emerging opportunities.Front Mol Biosci2023https://conductscience.org/library/papers/37780209PubMed
37242457Peptide Radioligands in Cancer Theranostics: Agonists and Antagonists.Pharmaceuticals (Basel)2023https://conductscience.org/library/papers/37242457PubMed
37109517Role of Exendin-4 Functional Imaging in Diagnosis of Insulinoma: A Systematic Review.Life (Basel)2023https://conductscience.org/library/papers/37109517PubMed
36569936GLP-1 receptor agonist as a modulator of innate immunity.Front Immunol2022https://conductscience.org/library/papers/36569936PubMed
33019671Beta Cell Imaging-From Pre-Clinical Validation to First in Man Testing.Int J Mol Sci2020https://conductscience.org/library/papers/33019671PubMed
31903131Advances in GLP-1 receptor targeting radiolabeled agent development and prospective of theranostics.Theranostics2020https://conductscience.org/library/papers/31903131PubMed
31378283Molecular imaging of β-cells: diabetes and beyond.Adv Drug Deliv Rev2019https://conductscience.org/library/papers/31378283PubMed
31070270Exendin-4 analogs in insulinoma theranostics.J Labelled Comp Radiopharm2019https://conductscience.org/library/papers/31070270PubMed
28295000Current Status of Radiopharmaceuticals for the Theranostics of Neuroendocrine Neoplasms.Pharmaceuticals (Basel)2017https://conductscience.org/library/papers/28295000PubMed
28025655Targets and probes for non-invasive imaging of β-cells.Eur J Nucl Med Mol Imaging2017https://conductscience.org/library/papers/28025655PubMed
27826137Imaging in pancreatic disease.Nat Rev Gastroenterol Hepatol2017https://conductscience.org/library/papers/27826137PubMed
27630114Glucagon-Like Peptide-1 and Its Class B G Protein-Coupled Receptors: A Long March to Therapeutic Successes.Pharmacol Rev2016https://conductscience.org/library/papers/27630114PubMed
27327034A Helix-Stabilizing Linker Improves Subcutaneous Bioavailability of a Helical Peptide Independent of Linker Lipophilicity.Bioconjug Chem2016https://conductscience.org/library/papers/27327034PubMed
26993859Effects of glucagon-like peptide-1 on the differentiation and metabolism of human adipocytes.Br J Pharmacol2016https://conductscience.org/library/papers/26993859PubMed
26909131Advancement in treatment and diagnosis of pancreatic cancer with radiopharmaceuticals.World J Gastrointest Oncol2016https://conductscience.org/library/papers/26909131PubMed
26194012Quantitative Impact of Plasma Clearance and Down-regulation on GLP-1 Receptor Molecular Imaging.Mol Imaging Biol2016https://conductscience.org/library/papers/26194012PubMed
26069859Dosimetry of [(68)Ga]Ga-DO3A-VS-Cys(40)-Exendin-4 in rodents, pigs, non-human primates and human - repeated scanning in human is possible.Am J Nucl Med Mol Imaging2015https://conductscience.org/library/papers/26069859PubMed
25973333Dosimetry of [(177)Lu]-DO3A-VS-Cys(40)-Exendin-4 - impact on the feasibility of insulinoma internal radiotherapy.Am J Nucl Med Mol Imaging2015https://conductscience.org/library/papers/25973333PubMed

See all 43 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
GLP1R2740PubTator's text mininghttps://conductscience.org/library/genes/2740

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/17575235

GET https://conductscience.org/api/papers/v1/17575235/cited_by?page=2